About Edoxaban

Edoxaban (Lixiana EU) is an oral anticoagulant medicine which is used for the prevention of blood clots and prevention of stroke. It is supplied by Daiichi Sankyo UK Ltd.

Edoxaban is licensed in the UK for patients diagnosed with atrial fibrillation, a condition that causes an irregular and often abnormally fast heart rate which disturbs the heart rhythm and can cause blood clots to form.

In 2015, the National Institute for Health and Care Excellence (NICE) issued guidance for  Edoxaban to be used to prevent stroke and systemic embolism in people with non-valvular atrial fibrillation (TA 355) and for treating and for preventing deep vein thrombosis and pulmonary embolism (TA 354)